This inventor holds 4 USPTO granted patents. Top assignee: California Institute of Technology. Active years: 1997-2002.
Location History:
- Pasadena, CA (US) (1997)
- Chicago, IL (US) (2000 - 2002)
Company Filing History:
Years Active: 1997-2002
Title: Paul R. Mueller: Innovator in Cell Cycle Regulation
Introduction
Paul R. Mueller is a distinguished inventor based in Chicago, IL (US). He has made significant contributions to the field of cell cycle regulation through his innovative research and inventions. With a total of 4 patents, his work focuses on the modulation of Myt1 activity, a critical component in the regulation of the cell cycle.
Latest Patents
One of his latest patents is titled "Method for identifying a reagent that modulates Myt1 activity." This invention provides a threonine/tyrosine kinase, Myt1, which phosphorylates the cyclin-dependent kinase, Cdc2, thereby regulating the cell cycle at the G2/M interphase. The patent also includes polynucleotides encoding the Myt1 polypeptide and antibodies that bind to Myt1. Additionally, it outlines methods for modulating Myt1 to prevent premature entry of the cell into mitosis or to accelerate entry into mitosis, as well as methods for identifying agents that modulate Myt1. Another significant patent is for the "Isolated Myt1 polypeptide," which shares similar features and applications as the previous invention.
Career Highlights
Paul R. Mueller is affiliated with the California Institute of Technology, where he continues to advance his research in cell cycle regulation. His work has garnered attention for its potential applications in cancer research and therapeutic development.
Collaborations
Throughout his career, Paul has collaborated with notable colleagues, including Akiko Kumagai and Thomas R. Coleman. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Paul R. Mueller is a prominent inventor whose work in cell cycle regulation has led to valuable innovations. His contributions continue to impact the scientific community and hold promise for future advancements in medical research.